Aldebaran Financial Inc. Amgen Inc Transaction History

Aldebaran Financial Inc.

$80.2 Million
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 21, 2021	SELL	$212.27 - $248.7 $209,510 - $245,466	-987 Closed	0 $0
Q2 2021 Jul 16, 2021	BUY	$233.58 - $259.14 $700 - $777	3 Added 0.3%	987 $242,000
Q1 2021 May 03, 2021	BUY	$221.91 - $258.6 $665 - $775	3 Added 0.31%	984 $245,000
Q4 2020 Feb 05, 2021	BUY	$216.38 - $257.67 $649 - $773	3 Added 0.31%	981 $226,000
Q3 2020 Oct 19, 2020	BUY	$234.65 - $260.95 $1,407 - $1,565	6 Added 0.62%	978 $249,000
Q2 2020 Jul 20, 2020	SELL	$197.81 - $242.74 $652,179 - $800,313	-3,297 Reduced 77.23%	972 $229,000
Q1 2020 Apr 24, 2020	BUY	$182.24 - $241.7 $546 - $725	3 Added 0.07%	4,269 $866,000
Q4 2019 Feb 10, 2020	SELL	$189.21 - $243.2 $406,423 - $522,393	-2,148 Reduced 33.49%	4,266 $1.03 Million
Q3 2019 Oct 21, 2019	BUY	$174.11 - $208.62 $348 - $417	2 Added 0.03%	6,414 $1.24 Million
Q2 2019 Aug 14, 2019	BUY	$166.7 - $195.41 $500 - $586	3 Added 0.05%	6,412 $1.18 Million
Q1 2019 Apr 23, 2019	BUY	$180.87 - $203.88 $542 - $611	3 Added 0.05%	6,409 $1.22 Million
Q4 2018 Feb 14, 2019	BUY	$178.4 - $208.25 $535 - $624	3 Added 0.05%	6,406 $1.25 Million
Q3 2018 Nov 08, 2018	BUY	$185.29 - $208.89 $370 - $417	2 Added 0.03%	6,403 $1.33 Million
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $215,532 - $242,089	-1,298 Reduced 16.86%	6,401 $1.18 Million
Q1 2018 Apr 24, 2018	BUY	$169.43 - $198.0 $508 - $594	3 Added 0.04%	7,699 $1.31 Million
Q4 2017 Mar 02, 2018	SELL	$168.79 - $188.59 $33,420 - $37,340	-198 Reduced 2.51%	7,696 $1.34 Million
Q3 2017 Nov 17, 2017	BUY	$167.29 - $191.0 $334 - $382	2 Added 0.03%	7,894 $1.47 Million
Q2 2017 Aug 28, 2017	BUY	N/A	7,892	7,892 $1.36 Million

Others Institutions Holding AMGN

# of Institutions

3,122

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Aldebaran Financial Inc., based on Form 13F filings with the SEC.

News

Stay updated on Aldebaran Financial Inc. with notifications on news.

Account